Diagnostic developer I-calQ has received a ninth patent for its point-of-care (POC) testing technology, which can be used with most smartphones and can test for potentially hundreds of analytes or agents.
I-calQ's technology uses the smartphone as a processor. Its camera is used to read a disposable test strip cassette, and a proprietary app that analyzes, calibrates, and quantifies results in about 10 minutes. It also has the ability to upload the data immediately.
The firm has already developed tests for thyroid stimulating hormone (TSH), hemoglobin, and cortisol, and it is adding infectious diseases to its repertoire. The company has two tests with CE Marks and one test pending U.S. Food and Drug Administration (FDA) submission.